Case report evaluates PSMA-targeted imaging's role in managing prostate and other malignancies, indicating challenges in treatment decisions.
Prostate-specific membrane antigen (PSMA) targeting PET imaging has an established role in prostate carcinoma for staging, recurrence evaluation, and selection for PSMA-targeted radiopharmaceutical therapy. We report a case with PSMA avid prostate, hepatic, and osseous lesions in a patient with synchronous malignancies complicating management.
No takes yet. Share an insight, caveat, or question.
Jindal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: